The classic thinking is that estrogen replacement
therapy does not stimulate the growth of most ovarian
cancers. There is mixed information in the literature. Most recently, the women's health initiative (WHI) study does suggest that ERT may be associated with an increased risk of ovarian cancer (note this is estrogen plus progesterone, there is no reported increase with estrogen by itself in WHI study).